pembrolizumab,mrna-4157
moderna,merck
['melanoma', 'moderna', 'merck']
. and build case for their personalised #melanoma vaccine at #asco23, with a 65% reduction in the risk of distant metastasis or death when used as an adjuvant therapy; ph3 due to start later this year 
https://t.co/O0ZJQGuINh, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate